Dessection of the cellular and serological immune repsonse in SARS-CoVo2-infected individuals, without need of hospitalization

eiden University Medical Center0 个研究点目标入组 10 人开始时间: 待定最近更新: 2024年6月11日

适应症

试验速览

暂无简介。

•To be eligible to participate in this study, a subject must meet all of the following criteria:
•Subject (male or female) tested positive for SARS-CoV2 by PCR (nasal swab, throat swab and/or sputum);
•Subject is an adult of 18-65 years old;
•Subject is able to understand the PIF document, written in Dutch;
•Subject is able to communicate well with the investigator in the Dutch language;
•Subject signed informed consent prior to any study-mandated procedure;
•Subject is living in Leiden or direct environment (e.g. within 10 km from LUMC), allowing for traveling by car, bike or by walking to LUMC (no public transportation).

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•Subject tested negative upon SARS-CoV2 PCR re-analysis of nasal swab at intake;
•Subject previously fainted before, during or after a medical procedure with needles;
•Subject received plasma or other blood products during the previous 3 months;
•Subject received a vaccination during the previous 3 months;
•Subject is obese with BMI =30, based on provide weight and length information;
•Subject has a pre-existing coagulopathy;
•Subject uses medication for a coagulopathy;
•Subject uses medication that suppresses the immune system;
•Subject has an auto-immune disease or another immune disease;
•Subject has another infection in addition to the SARS-CoV2 infection;
•Subject participated in a clinical trial within 6 months prior to this study;
•For women: subject is pregnant or is providing breast-feeding.

发起方

eiden University Medical Center